PureTech Health (PRTC) Equity Average (2020 - 2023)

PureTech Health (PRTC) has 4 years of Equity Average data on file, last reported at $503.1 million in Q4 2023.

• Quarterly Equity Average fell 11.4% year-over-year to $503.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $503.1 million (down 11.4% YoY) and the FY2023 annual result came in at $503.1 million, down 11.4% from the prior year.
• Equity Average eased to $503.1 million in Q4 2023 per PRTC's latest filing, from $567.9 million in the prior quarter.
• Across five years, Equity Average topped out at $668.9 million in Q4 2020 and bottomed at $503.1 million in Q4 2023.
• The 4-year median for Equity Average is $599.7 million (2021), against an average of $592.9 million.
• The widest annual swing landed in 2021, when Equity Average retreated 5.57%; it then slipped 11.4% in 2023.
• Tracing PRTC's Equity Average over 4 years: stood at $668.9 million in 2020, then dropped by 5.57% to $631.6 million in 2021, then fell by 10.1% to $567.9 million in 2022, then fell by 11.4% to $503.1 million in 2023.
• Per Business Quant, the three latest PRTC Equity Average figures stand at $503.1 million (Q4 2023), $567.9 million (Q4 2022), and $631.6 million (Q4 2021).

Peer Comparison